Alcohol consumption and colon cancer prognosis among participants in north central cancer treatment group phase III trial N0147
Open Access
- 8 April 2016
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 139 (5) , 986-995
Abstract
Alcohol consumption is associated with a modest increased risk of colon cancer, but its relationship with colon cancer survival has not been elucidated. Using data from a phase III randomized adjuvant trial, we assessed the association of alcohol consumption with colon cancer outcomes. Patients completed a risk factor questionnaire before randomization to FOLFOX or FOLFOX + cetuximab (N = 1984). Information was collected on lifestyle factors, including smoking, physical activity and consumption of different types of alcohol. Cox models assessed the association between alcohol consumption and outcomes of disease‐free survival (DFS), time‐to‐recurrence (TTR) and overall survival (OS), adjusting for age, sex, study arm, body mass, smoking, physical activity and performance status. No statistically significant difference in outcomes between ever and never drinkers were noted [hazard ratio (HR)DFS = 0.86, HRTTR = 0.87, HROS = 0.86, p‐values = 0.11–0.17]. However, when considering alcohol type, ever consumers of red wine (n = 628) had significantly better outcomes than never consumers (HRDFS = 0.80, HRTTR = 0.81, HROS = 0.78, p‐values = 0.01–0.02). Favorable outcomes were confirmed in patients who consumed 1‐30 glasses/month of red wine (n = 601, HR = 0.80–0.83, p‐values = 0.03–0.049); there was a suggestion of more favorable outcomes in patients who consumed >30 glasses/month of red wine (n = 27, HR = 0.33–0.38, p‐values = 0.05–0.06). Beer and liquor consumption were not associated with outcomes. Although alcohol consumption was not associated with colon cancer outcomes overall, mild to moderate red wine consumption was suggestively associated with longer OS, DFS and TTR in stage III colon cancer patients.Keywords
Funding Information
- National Cancer Institute
- National Institutes of Health (K07CA172298, U10CA180821, U10CA180882, U10CA025224, U10CA180888)
This publication has 44 references indexed in Scilit:
- Effect of Oxaliplatin, Fluorouracil, and Leucovorin With or Without Cetuximab on Survival Among Patients With Resected Stage III Colon CancerJAMA, 2012
- Alcohol Intake and Colorectal Cancer Risk by Molecularly Defined Subtypes in a Prospective Study of Older WomenCancer Prevention Research, 2011
- Prediagnostic smoking history, alcohol consumption, and colorectal cancer survivalCancer, 2011
- Alcohol Consumption and Breast Cancer Recurrence and Survival Among Women With Early-Stage Breast Cancer: The Life After Cancer Epidemiology StudyJournal of Clinical Oncology, 2010
- Alcohol consumption and non-Hodgkin lymphoma survivalJournal of Cancer Survivorship, 2009
- Differential Effects of Wine Consumption on Colorectal Cancer Outcomes Based on Family History of the DiseaseNutrition and Cancer, 2007
- Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancerInternational Journal of Cancer, 2006
- Alcohol intake and colorectal cancer risk: A dose–response meta‐analysis of published cohort studiesInternational Journal of Cancer, 2006
- Alcohol consumption and the etiology of colorectal cancer: A review of the scientific evidence from 1957 to 1991Nutrition and Cancer, 1992
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958